RecruitingNot ApplicableNCT06275737

POP-UP: a Single-arm, Two-cohort Study: Trimodal Prehab for Upper GI and Pancreatic Cancer

Trimodal Peri Operative Prehabilitation for Upper Oesogastric and Pancreatic Cancer: A Multicenter, Two-cohort, Open-label, Single-arm POP-UP GERCOR Study


Sponsor

GERCOR - Multidisciplinary Oncology Cooperative Group

Enrollment

72 participants

Start Date

Jun 24, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This is a multicenter, two-cohort, open-label, single-arm feasibility study. The primary objective is to assess the feasibility of the 8-week trimodal prehabilitation program alongside perioperative triplet chemotherapy in eligible patients with localized pancreatic ductal adenocarcinoma (PDAC) or oesogastric cancer (OGC) .


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study, called POP-UP, is testing a three-part preparation program (exercise, nutrition, and psychological support) for people undergoing chemotherapy before surgery for pancreatic or stomach/esophageal cancer. The goal is to help patients get stronger before surgery to improve their recovery. **You may be eligible if...** - You are over 18 years old (if 75 or older, you must pass a geriatric fitness screen) - You have been diagnosed with localized pancreatic cancer or stomach/esophageal cancer confirmed by tissue sample - You are scheduled to receive at least 4 cycles (about 8 weeks) of chemotherapy before surgery - You are in reasonably good physical condition (ECOG score 0-1) - You have not had prior treatment for this cancer - You are enrolled in a national health insurance program **You may NOT be eligible if...** - Your cancer has spread to other parts of the body (metastatic disease) - Your tumor is not an adenocarcinoma (a specific type of cancer) - You have heart, lung, psychiatric, or musculoskeletal conditions that prevent safe exercise Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPrehabilitation program

Cohort 1 - Prehabilitation program will be implemented during the last cycles of neoadjuvant chemotherapy (cycle 5 - cycle 6 or cycle 6 - cycle 8) and the weeks preceding surgery (planned 3-4 weeks after the last chemotherapy cycle) Cohort 2 - Prehabilitation program will be implemented during the last cycles of neoadjuvant chemotherapy (cycle 2 - cycle 4) and the weeks preceding surgery (planned 3-4 weeks after the last chemotherapy cycle)


Locations(4)

Centre Hospitalier Universitaire de Lille

Lille, France

Institut Paoli Calmettes

Marseille, France

Institut Curie

Saint-Cloud, France

Institut de Cancerologie de L'Ouest Rene Gauducheau

Saint-Herblain, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06275737


Related Trials